TNT

Patients with gastrointestinal cancer commonly have poor tolerability to total neoadjuvant therapy, which reduces cancer control and survival benefit of this treatment. This study will investigate the dose-response of aerobic training (AT) on total neoadjuvant therapy tolerability in patients with LARC. This will help support integration of AT into clinical cancer care.

Recruitment Sites:
New York, NY